{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:45:22Z","timestamp":1763642722407,"version":"3.45.0"},"reference-count":12,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Psoriasis vulgaris features epidermal barrier dysfunction. Materials and Methods: Barrier function changes were prospectively evaluated over 12 weeks during TNF-\u03b1 inhibition with adalimumab, along with concurrent changes in disease severity and quality of life. Adults with moderate-to-severe plaque psoriasis initiating adalimumab (80 mg loading on day 1; 40 mg every other week thereafter, starting day 8) underwent assessments at baseline and at week 12 (n = 9; mean age 44.1 \u00b1 14.9 years, range 20\u201361). Transepidermal water loss (TEWL; g\/m2\/h) and skin pH were measured at the elbow, lower leg, abdomen, back, and scalp; PASI, BSA, and DLQI were recorded. The measurements were standardized, though room temperature\/humidity were not identical between visits. Results: The clinical indices improved markedly and TEWL also decreased at all sites\u2014the elbow, lower leg, abdomen, back, and scalp\u2014indicating barrier recovery; in contrast, the pH remained within a mildly acidic range at all sites. Lesion-to-non-lesion conversion occurred, and no site worsened. Conclusions: In summary, 12 weeks of adalimumab were associated with a notable clinical improvement and consistent, site-spanning reductions in TEWL, whereas skin surface pH showed no material change. TEWL appears to be a sensitive objective adjunct to clinical indices for monitoring response.<\/jats:p>","DOI":"10.3390\/medicina61112070","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:02:42Z","timestamp":1763640162000},"page":"2070","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Immunomodulatory Therapy on the Skin Barrier Function in Patients with Psoriasis Vulgaris"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4351-7387","authenticated-orcid":false,"given":"Anete","family":"M\u0101lkalne","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Riga Stradins University, LV-1007 R\u012bga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0939-8003","authenticated-orcid":false,"given":"Vanda","family":"Bondare-Ansberga","sequence":"additional","affiliation":[{"name":"Department of Doctoral Studies, Riga Stradins University, Riga 1st Hospital, LV-1007 R\u012bga, Latvia"},{"name":"Riga 1st Hospital, LV-1001 R\u012bga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilona","family":"Hartmane","sequence":"additional","affiliation":[{"name":"Riga 1st Hospital, LV-1001 R\u012bga, Latvia"},{"name":"Department of Dermatology and Venereology, Riga Stradins University, LV-1007 R\u012bga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4684-0892","authenticated-orcid":false,"given":"Ingm\u0101rs","family":"Mika\u017e\u0101ns","sequence":"additional","affiliation":[{"name":"Riga 1st Hospital, LV-1001 R\u012bga, Latvia"},{"name":"Department of Dermatology and Venereology, Riga Stradins University, LV-1007 R\u012bga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lelde","family":"Reinberga","sequence":"additional","affiliation":[{"name":"Riga 1st Hospital, LV-1001 R\u012bga, Latvia"},{"name":"Department of Dermatology and Venereology, Riga Stradins University, LV-1007 R\u012bga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Montero-Vilchez, T., Segura-Fern\u00e1ndez-Nogueras, M.-V., P\u00e9rez-Rodr\u00edguez, I., Soler-Gongora, M., Martinez-Lopez, A., Fern\u00e1ndez-Gonz\u00e1lez, A., Molina-Leyva, A., and Arias-Santiago, S. (2021). Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity. J. Clin. Med., 10.","DOI":"10.3390\/jcm10020359"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Orsmond, A., Bereza-Malcolm, L., Lynch, T., March, L., and Xue, M. (2021). Skin barrier dysregulation in psoriasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910841"},{"key":"ref_3","first-page":"36","article-title":"Paradoxical effect on epidermal barrier of anti-TNF-\u03b1 treatment for psoriasis","volume":"15","author":"Gualdi","year":"2022","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4103\/idoj.IDOJ_180_18","article-title":"Transepidermal Water Loss in Psoriasis: A Case-control Study","volume":"10","author":"Nikam","year":"2019","journal-title":"Indian Dermatol. Online J."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Maroto-Morales, D., Montero-Vilchez, T., and Arias-Santiago, S. (2021). Study of skin barrier function in psoriasis: The impact of emollients. Life, 11.","DOI":"10.3390\/life11070651"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Noor, A.A.M., Azlan, M., and Redzwan, N.M. (2022). Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020498"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100591","DOI":"10.1016\/j.jlr.2024.100591","article-title":"Guselkumab treatment normalizes the stratum corneum ceramide profile and alleviates barrier dysfunction in psoriasis: Results of a randomized controlled trial","volume":"65","author":"Rousel","year":"2024","journal-title":"J. Lipid Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2147\/CCID.S462797","article-title":"The role of interleukin 23\/17 axis in psoriasis management: A comprehensive review of clinical trials","volume":"17","author":"Potestio","year":"2024","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: From keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2125.2008.03263.x","article-title":"Adalimumab in dermatology","volume":"66","author":"Traczewski","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1467-2494.2006.00344.x","article-title":"Natural skin surface pH is on average below 5, which is beneficial for its resident flora","volume":"28","author":"Lambers","year":"2006","journal-title":"Int. J. Cosmet. Sci."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/11\/2070\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:32:30Z","timestamp":1763641950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/11\/2070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":12,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["medicina61112070"],"URL":"https:\/\/doi.org\/10.3390\/medicina61112070","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}